Treatment of Pediatric Hypertension With Altace Trial

Sponsor
Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00044265
Collaborator
Wyeth is now a wholly owned subsidiary of Pfizer (Industry)
310
30
28.1
10.3
0.4

Study Details

Study Description

Brief Summary

Ramipril is an ACE inhibitor that has been marketed in the US for the treatment of hypertension since 1991. It has been shown to be effective in reducing both systolic and diastolic blood pressure in adults when used once daily. ACE inhibitors are frequently used to treat hypertension in children, however ramipril has not been extensively tested in children, and information regarding the efficacy and safety would therefore be of benefit to children. This study is designed to demonstrate the efficacy and safety of ramipril in the treatment of hypertension in children ages 6 through 16 years.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

In adults, common side effects include persistent dry mouth, dizziness, fatigue, and headache. Rare cases of angioedema have been reported. When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, ramipril should be discontinued as soon as possible. Ramipril is contraindicated in patients who are hypersensitive to the product or have a history of angioedema related to previous treatment with an ACE inhibitor.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents
Study Start Date :
Jul 1, 2002
Study Completion Date :
Nov 1, 2004

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 16 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • Males or females age 6 to 16 years. All female subjects ≥ 8 years of age must have a negative urine pregnancy test and must use an acceptable method of contraception, including abstinence, a barrier method (diaphragm or condom), Depo-Provera, or an oral contraceptive, for the duration of the study.

    • Weight ≥ 20 kg.

    • Parents/guardians must be able to demonstrate their ability to use the home blood pressure device to monitor blood pressure.

    • Sitting systolic blood pressure or sitting diastolic blood pressure ≥ the 95th percentile for age, gender and height; or diabetes mellitus or chronic renal insufficiency (as evidenced by GFR 40-70 mL/min/1.73 m2) and a sitting systolic blood pressure or sitting diastolic blood pressure ≥ the 90th percentile for age, gender, and height.

    Exclusion criteria:
    • Severe hypertension documented by (1) Sitting systolic blood pressure or sitting diastolic blood pressure more than 20 mmHg above the 95th percentile for age, gender, and height without antihypertensive therapy, (2) Sitting systolic blood pressure or sitting diastolic blood pressure more than 12 mmHg above the 95th percentile for age, gender, and height while receiving active therapy, or (3) hypertensive encephalopathy within the previous 5 months.

    • Currently receiving more than one antihypertensive medication including: ACE inhibitors, angiotensin receptor inhibitors, beta blockers, calcium channel blockers, diuretics.

    • Receiving lithium, potassium supplements, monoamine oxidase inhibitors, or major tranquilizers (Note: Stimulant medications for behavioral disorders, corticosteroids, and non-steroidal anti-inflammatory agents for chronic pain management are permitted during the trial provided the subject's dosage is anticipated to remain unchanged throughout the duration of the study.)

    • A history of cardiomyopathy, clinically significant structural heart disease or atrioventricular conduction disturbance, sick sinus syndrome, atrial flutter, atrial fibrillation, clinically significant bradycardia or an accessory bypass tract, or clinical symptoms of congestive heart failure.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Birmingham Alabama United States 35233
    2 Sante Los Angeles Los Angeles California United States 90010
    3 Neufeld Medical Group Los Angeles California United States 90048
    4 UCLA Medical Center Los Angeles California United States 90095
    5 Medical College of Georgia Augusta Georgia United States 30912
    6 Kapiolani Medical Center for Women and Children Honolulu Hawaii United States 96813
    7 Nephrology and Hypertension Consultants Park Ridge Illinois United States 60068
    8 University of Louisville Louisville Kentucky United States 40202
    9 Tulane University Health Sciences Center New Orleans Louisiana United States 70112
    10 University of Maryland Baltimore Maryland United States 21201
    11 Children's Hospital of Michigan Detroit Michigan United States 48201
    12 Univ of Missouri, Children's Mercy Hospital and Clinics Kansas City Missouri United States 64108
    13 St. Louis Children's Hospital St. Louis Missouri United States 63110
    14 Montefiore Medical Center c/o BRANY Bronx New York United States 10467
    15 North Shore Univ Hospital c/o BRANY Great Neck New York United States 11021
    16 Children's Hospital Medical Center Cincinnati Ohio United States 45229
    17 University Hospitals of Cleveland Cleveland Ohio United States 44106
    18 Cleveland Clinic Foundation Cleveland Ohio United States 44195
    19 PCTI at Columbus Children's Hospital Columbus Ohio United States 43205
    20 Oregon Health and Science University Portland Oregon United States 97201
    21 Hershey Medical Center Hershey Pennsylvania United States 17033
    22 The Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104
    23 Thomas Jefferson University Hospital Philadelphia Pennsylvania United States 19107
    24 The Children's Hospital of Pittsburgh Pittsburgh Pennsylvania United States 15213
    25 Le Bonheur Children's Hospital - Univ of Tennessee Memphis Tennessee United States 38103
    26 Vanderbilt University Medical Center Nashville Tennessee United States 37232
    27 Texas Children's Hospital Houston Texas United States 77030
    28 University of Texas Medical Center Houston Texas United States 77030
    29 University of Virginia Charlottesville Virginia United States 22908
    30 University of Wisconsin Madison Wisconsin United States 53792

    Sponsors and Collaborators

    • Pfizer
    • Wyeth is now a wholly owned subsidiary of Pfizer

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00044265
    Other Study ID Numbers:
    • K726-01-4002
    First Posted:
    Aug 26, 2002
    Last Update Posted:
    Jun 7, 2012
    Last Verified:
    Jun 1, 2012
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 7, 2012